In summary, we show that CB1 and CB2 receptor antagonists reversed the suppression of 5-HT-induced apnea by locally-injected dronabinol into the nodose ganglia, but did not reverse increases phasic activation of the genioglossus. The gene discussed is CNR1; the disease is Apnea.